TR200003301T2 - Morfolino eterler - Google Patents

Morfolino eterler

Info

Publication number
TR200003301T2
TR200003301T2 TR2000/03301T TR200003301T TR200003301T2 TR 200003301 T2 TR200003301 T2 TR 200003301T2 TR 2000/03301 T TR2000/03301 T TR 2000/03301T TR 200003301 T TR200003301 T TR 200003301T TR 200003301 T2 TR200003301 T2 TR 200003301T2
Authority
TR
Turkey
Prior art keywords
ethers
morfolino
new
relates
fungal
Prior art date
Application number
TR2000/03301T
Other languages
English (en)
Inventor
M. Bueno Jose
Chicharro Gonzalo Jesus
Coteron Jose-Miguel
Carlos Cuevas Juan
M. Fiandor Jose
Mallo Araceli̇
Original Assignee
Glaxo Wellcome S.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome S.A filed Critical Glaxo Wellcome S.A
Publication of TR200003301T2 publication Critical patent/TR200003301T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)

Abstract

Bu bulus anti-fungal etkinligi olan yeni morfolino eterlere iliskindir. Daha özel olarak yeni sordarisin türevlerine, hazirlanmalari için islemlere, onlari içeren farmasötik bilesimlere ve tipta kullanimlarina, daha özel olarak insanlar dahil hayvanlarda fungal enfeksiyonlarin neden oldugu hastaliklarin önlenmesine veya tedavisine iliskindir.
TR2000/03301T 1998-05-11 1999-05-07 Morfolino eterler TR200003301T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98500117 1998-05-11
EP98500204 1998-09-18

Publications (1)

Publication Number Publication Date
TR200003301T2 true TR200003301T2 (tr) 2001-02-21

Family

ID=26151831

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03301T TR200003301T2 (tr) 1998-05-11 1999-05-07 Morfolino eterler

Country Status (13)

Country Link
EP (1) EP1077959A1 (tr)
JP (1) JP2002514632A (tr)
KR (1) KR100625146B1 (tr)
CN (1) CN1174971C (tr)
AR (1) AR016261A1 (tr)
AU (1) AU763088B2 (tr)
BR (1) BR9910377A (tr)
CA (1) CA2331584A1 (tr)
MA (1) MA26628A1 (tr)
PE (1) PE20000479A1 (tr)
TR (1) TR200003301T2 (tr)
TW (1) TW585858B (tr)
WO (1) WO1999058512A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001286208A1 (en) * 2000-09-13 2002-03-26 Sankyo Company Limited Zofimarin derivatives having oxazepam ring
RU2259825C9 (ru) * 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
EP3252043B1 (en) * 2015-01-30 2020-09-30 NOF Corporation Cationic lipid

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465771A (de) * 1965-12-06 1968-11-30 Sandoz Ag Verfahren zur Herstellung eines neuen Antibioticums
JPH0615555B2 (ja) * 1985-08-14 1994-03-02 三共株式会社 抗生物質ゾフイマリン
EP0711784A1 (en) * 1994-11-08 1996-05-15 Glaxo, S.A. Antifungal Sordarin derivatives
EP0712859A1 (en) * 1994-11-08 1996-05-22 Glaxo, S.A. Antifungal Sordarin derivatives
PE49696A1 (es) * 1994-11-08 1996-12-05 Glaxo Wellcome Sa Compuesto carbociclico
EP0711783A1 (en) * 1994-11-08 1996-05-15 Glaxo, S.A. Antifungal Sordarin derivatives
WO1997042195A1 (en) * 1996-05-08 1997-11-13 Glaxo Wellcome S.A. Process for the preparation of an indacene compound
EP0938307B1 (en) * 1996-09-18 2003-05-07 Merck & Co., Inc. Sordarin and derivatives thereof for use as crop antifungal agents
ES2215220T3 (es) * 1996-10-07 2004-10-01 MERCK & CO., INC. Derivados de sordarina.
NZ502763A (en) * 1997-08-22 2002-03-28 Merck & Co Inc 4-cyano-4-deformylsordarin derivatives
WO1999009975A1 (en) * 1997-08-22 1999-03-04 Merck & Co., Inc. 4-cyano-4-deformylsordaricin derivatives

Also Published As

Publication number Publication date
AR016261A1 (es) 2001-06-20
AU4258899A (en) 1999-11-29
WO1999058512A1 (en) 1999-11-18
KR20010025009A (ko) 2001-03-26
TW585858B (en) 2004-05-01
CN1309651A (zh) 2001-08-22
JP2002514632A (ja) 2002-05-21
AU763088B2 (en) 2003-07-10
EP1077959A1 (en) 2001-02-28
CA2331584A1 (en) 1999-11-18
PE20000479A1 (es) 2000-05-29
MA26628A1 (fr) 2004-12-20
CN1174971C (zh) 2004-11-10
KR100625146B1 (ko) 2006-09-20
BR9910377A (pt) 2001-01-16

Similar Documents

Publication Publication Date Title
NO20053855D0 (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
NO20060230L (no) Nye aminobenzofenonforbindelser
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
ATE448232T1 (de) Substituierte heterozyklen
TR200103336T2 (tr) Amid türevleri.
GB0222495D0 (en) Compounds
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
DE50310516D1 (de) Fredericamycin-derivate
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
ES2243579T3 (es) Derivados de pirazolopirideno.
TR200101649T2 (tr) Piperazin türevleri.
ATE333451T1 (de) Verwendung von nitrilenverbindungen als arztneimittel
TR200100637T2 (tr) Yeni doğal ürün türevleri
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
SE0300457D0 (sv) Novel compounds
TR200003301T2 (tr) Morfolino eterler
NO20053562L (no) Nye aminobenzofenonforbindelser
ATE241640T1 (de) Fusidinsäure-derivate
NO20020914L (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
HUP0202888A2 (hu) Xenogén oligo- és/vagy poliribonukleotidokat tartalmazó gyógyszerkészítmény